Russia To Start Exports Of HPV Vaccines To Friendly Countries
Russia’s Nanolek is investing in a second HPV vaccine production line to satisfy markets in the Commonwealth of Independent States, Eurasian Economic Union, Central and Southeast Asia as well as Africa. The line will increase vaccine production to 6 million doses a year and should be completed by 2027.
Русский







